A Longitudinal Analysis of IDO and PDL1 Expression during Immune- or Targeted Therapy in Advanced Melanoma. [electronic resource]
Producer: 20181218Description: 218-225 p. digitalISSN:- 1476-5586
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- B7-H1 Antigen -- antagonists & inhibitors
- Biomarkers, Tumor -- antagonists & inhibitors
- Female
- Follow-Up Studies
- Humans
- Immunotherapy
- Indoleamine-Pyrrole 2,3,-Dioxygenase -- antagonists & inhibitors
- Longitudinal Studies
- Male
- Melanoma -- drug therapy
- Middle Aged
- Molecular Targeted Therapy
- Prognosis
- Survival Rate
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.